Synthetic peptide, and cosmetic composition or pharmaceutical composition and application thereof
US-2024352069-A1 · Oct 24, 2024 · US
US10370409B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10370409-B2 |
| Application number | US-201214354031-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 25, 2012 |
| Priority date | Oct 25, 2011 |
| Publication date | Aug 6, 2019 |
| Grant date | Aug 6, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure is directed to a novel class of peptide-like oligomers called peptide tertiary amides (PTAs) and a combinatorial library of PTAs along with synthetic routes for the preparation of large combinatorial libraries of these compounds. The peptide tertiary amides provide an exceptional source of high affinity and selective protein ligands that are useful as tools for biological research and as drug leads, among others.
Opening claim text (preview).
What is claimed is: 1. A process for preparing a peptide tertiary amide of formula (I) or its enantiomer with the opposite stereochemistry at Cα: wherein R 1 is selected from optionally substituted C 1 -C 10 alkyl, optionally substituted aryl, optionally substituted alkaryl, optionally substituted alkoxyl, optionally substituted heteroaryl, arylalkoxyl, optionally substituted acyl, OH, OR′, NH 2 , NHR′, NR′ 2 , SH, SR′, C(O)R′, and an amino acid side chain; R 2 is selected from optionally substituted C 2 -C 10 alkyl, optionally substituted aryl, optionally substituted alkaryl, optionally substituted alkoxyl, optionally substituted heteroaryl, arylalkoxyl, optionally substituted acyl, OH, OR′, NH 2 , NHR′, NR′ 2 , SH, SR′, C(O)R′, and an amino acid side chain; wherein R′ is selected from optionally substituted C 1 -C 10 alkyl, optionally substituted C 1 -C 10 alkenyl, optionally substituted C 1 -C 10 alkynyl, optionally substituted aryl, optionally substituted alkaryl, and optionally substituted acyl; comprising: oxidizing a primary amine of an amino acid of formula (II) with an oxidizing agent followed by treatment with a nucleophilic bromide source to give an optically pure 2-bromo acid of formula (III): wherein the synthesis further comprises a solid or semi-solid phase synthetic step wherein the solid or semi-solid phase synthetic step comprises bonding the 2-bromo acid of formula (III) to the solid-phase bead using a coupling agent in a solvent to give a compound of formula (V) wherein the compound of formula (V) is reacted with an amine of formula (IV) H 2 N—R 2 (IV) to give a compound of formula (VI): and wherein the compound of formula (VI) is further reacted with additional 2-bromo acid of formula (III) followed by an amine of formula (IV) to obtain oligomers of the compound of formula (VI). 2. The process of claim 1 , wherein the oxidizing agent comprises one of nitrous acid and sulfuric acid. 3. The process of claim 1 , wherein the bromide source comprises a chemical selected from the group consisting of potassium bromide, hydrogen bromide, and sodium bromide. 4. The process of claim 1 , wherein the amine of formula (IV) is a primary amine. 5. The process of claim 1 , wherein the peptide tertiary amide comprises at least 90% enantiomeric excess of the (R) enantiomer. 6. The process of claim 1 , wherein the peptide tertiary amide comprises at least 90% enantiomeric excess of the (S) enantiomer. 7. The process of claim 1 , wherein the peptide tertiary amide comprises one or more Cα- and N-substitutions. 8. The process of claim 1 , wherein the solid-phase comprises a bead. 9. The process of claim 8 , wherein the solid-phase comprises a bead having a methionine linker. 10. The process of claim 1 , wherein the solvent is N,N-dimethylformamide. 11. The process of claim 1 , wherein the oligomers of the compound of formula (VI) are released from the bead by cleaving the oligomers from the solid-phase bead by reacting the bound oligomer with cyanogen bromide.
Methods of identifying protein-protein interactions in protein mixtures · CPC title
having 5 to 11 amino acids · CPC title
from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines · CPC title
having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated (peptides C07K) · CPC title
by chemical synthesis · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.